Consultant Haematologist
Pathology
University College Cork
Ireland

E: maryr.cahill@hse.ie

Book Chapters

 YearPublication
(2013)'“Thrombocytopenia –perils and pitfalls”'
Cahill MR (2013) '“Thrombocytopenia –perils and pitfalls”' In: Learning Clinical Skils; peirls pitfalls ans tips for the OSCE. Nova: Nova Science Publishers. [No details]

Peer Reviewed Journals

 YearPublication
(2013)'A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia'
Maung SW, Leahy M, O'Leary HM, Khan I, Cahill MR, Gilligan O, Murphy P, McPherson S, Jackson F, Ryan M, Hennessy B, McHugh J, Goodyer M, Bacon L, O'Gorman P, Nee A, O'Dwyer M, Enright H, Saunders J, O'Keeffe D (2013) 'A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia' [DOI] [Details]
(2013)'Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein'
Elzinga BM, Nyhan MJ, Crowley LC, O'Donovan TR, Cahill MR, McKenna SL (2013) 'Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein' [DOI] [Details]
(2010)'Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia'
Langabeer SE, Crampe M, Haslam K, Kelly J, Cahill MR; (2010) 'Sustained clinical remission despite suboptimal molecular response to imatinib in e1a2 BCR-ABL chronic myeloid leukemia' [DOI] [Details]
(2010)'Phase I/II safety study of transfusion of prion-filtered red cell concentrates in transfusion-dependent patients'
Cahill MR, Murphy T, Khan M, Fagan J, Murphy WG (2010) 'Phase I/II safety study of transfusion of prion-filtered red cell concentrates in transfusion-dependent patients' [DOI] [Details]
(2009)'Can mean platelet component be used as an index of platelet activity in stable coronary artery disease?'
Cooke J, Murphy T, McFadden E, O'Reilly M, Cahill MR; (2009) 'Can mean platelet component be used as an index of platelet activity in stable coronary artery disease?' [DOI] [Details]
(2007)'Warfarin prevalence, indications for use and haemorrhagic events'
Ouirke, W.;Cahill, M.R.;Perera, K.;Sargent, J.;Conway, J. (2007) 'Warfarin prevalence, indications for use and haemorrhagic events' [Full Text] [Details]
(2006)'Writing to patients: a randomised controlled trial'
O'Reilly M.; Cahill MR; Perry IJ; (2006) 'Writing to patients: a randomised controlled trial' [Full Text] [Details]
(2005)'Writing to patients: 'putting the patient in the picture''
Reilly MO, Cahill M, Perry IJ.; (2005) 'Writing to patients: 'putting the patient in the picture'' [Full Text] [Details]
(2005)'The issue of Anti-D: An integrated seamless approach from recognition of need to bedside administration'
Ryan, MJ,Joyce, S,O'Brien, N,Lynch, E,Burke, G,Cahill, MR (2005) 'The issue of Anti-D: An integrated seamless approach from recognition of need to bedside administration' [Details]
(2005)'Detection of Aspirin Resistance by PFA-100: Prevalence and Aspirin Compliance in Patients with Chronic Stable Angina'
Crowe B, Abbas S, Meany B, de Haan J, Cahill MR.; (2005) 'Detection of Aspirin Resistance by PFA-100: Prevalence and Aspirin Compliance in Patients with Chronic Stable Angina' [Details]
(2005)'Duration of increased bleeding tendency after cessation of aspirin therapy'
Cahill RA, McGreal GT, Crowe BH, Ryan DA, Manning BJ, Cahill MR, Redmond HP (2005) 'Duration of increased bleeding tendency after cessation of aspirin therapy' [DOI] [Details]
(2005)'Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003. Ir J Med Sci. 2005 Apr-Jun;174(2):26-32'
Hayden PJ, O'Driscoll A, Gardiner N, Swords R, Sargent J, Ainle FN, Fortune A, Murphy PT, Leahy M, Jackson F, Ryan M, Hennessy B, Cahill M, Crotty GM, Enright H, Conneally E, Vandenberghe E, McCann SR, Browne PV.; (2005) 'Autologous stem cell transplantation in myeloma: the St James's Hospital experience, 1997-2003. Ir J Med Sci. 2005 Apr-Jun;174(2):26-32' [Details]
(2004)'Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy'
Haider I, Cahill M.; (2004) 'Fatal thrombocytopaenia temporally related to the administration of alemtuzumab (MabCampath) for refractory CLL despite early discontinuation of therapy' [Details]
(2004)'Successful intra-articular chemotherapy for relapsed acute myeloid leukaemia infiltrating the knee joint. '
Ramadan K, Cahill M.; (2004) 'Successful intra-articular chemotherapy for relapsed acute myeloid leukaemia infiltrating the knee joint. ' [Details]
(2003)'Cerebral venous sinus thrombosis precipitated by Graves' disease and Factor V Leiden mutation'
Molloy E, Cahill M, O'Hare JA.; (2003) 'Cerebral venous sinus thrombosis precipitated by Graves' disease and Factor V Leiden mutation' [Details]
(2003)'Haemovigilance is associated with decreased use and improved appropriateness of blood transfusion'
Cahill, M. R. and Joyce, S. and O'Brien, N. and Casey, M. (2003) 'Haemovigilance is associated with decreased use and improved appropriateness of blood transfusion' [DOI] [Details]
(2001)'P-selectin and glycoprotein 53 expression in myeloproliferative disorders'
Cahill MR.; (2001) 'P-selectin and glycoprotein 53 expression in myeloproliferative disorders' [Details]
(2001)'The effects of ropivacaine hydrochloride on platelet function: an assessment using the platelet function analyser (PFA-100)'
Porter J, Crowe B, Cahill M, Shorten G.; (2001) 'The effects of ropivacaine hydrochloride on platelet function: an assessment using the platelet function analyser (PFA-100)' [Details]
(1998)'The rational use of platelet transfusions in children'
Cahill MR, Lilleyman JS.; (1998) 'The rational use of platelet transfusions in children' [Details]
(1998)'Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit'
Cahill MR, Macey MG, Cavenagh JD, Newland AC (1998) 'Protein A immunoadsorption in chronic refractory ITP reverses increased platelet activation but fails to achieve sustained clinical benefit' [Details]
(1998)'Adhesion molecules in clinical medicine'
Cavenagh JD, Cahill MR, Kelsey SM (1998) 'Adhesion molecules in clinical medicine' [DOI] [Details]
(1997)'Inflammation, aspirin, and the risk of cardiovascular disease'
Cahill MR; Perry IJ.; (1997) 'Inflammation, aspirin, and the risk of cardiovascular disease' [DOI] [Full Text] [Details]
(1997)'Clinical significance of platelet size in inflammatory bowel disease?'
Collins CE, Cahill MR, Rampton DS (1997) 'Clinical significance of platelet size in inflammatory bowel disease?' [Details]
(1997)'Is it refractory idiopathic thrombocytopenic purpura?'
Cahill MR, Newland AC.; (1997) 'Is it refractory idiopathic thrombocytopenic purpura?' [Details]
(1997)'Haemophilia'
Cahill Mary R.; Colvin BT; (1997) 'Haemophilia' [Full Text] [Details]
(1996)'Correlation of GP53 and P-selectin expression in myeloproliferative disorders and normal controls. '
Cahill MR, Macey MG, Newland AC.; (1996) 'Correlation of GP53 and P-selectin expression in myeloproliferative disorders and normal controls. ' [Details]
(1996)'Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease'
Cahill MR, Macey MG, Dawson JR, Newland AC.; (1996) 'Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease' [Details]
(1995)'Treatment of acute myeloid leukaemia in pregnancy'
Cavenagh JD, Richardson DS, Cahill MR, Bernard T, Kelsey SM, Newland AC (1995) 'Treatment of acute myeloid leukaemia in pregnancy' [Details]
(1994)'Effect of fixation on quantification of the expression of leucocyte function-associated surface antigens'
McCarthy DA, Macey MG, Cahill MR, Newland AC (1994) 'Effect of fixation on quantification of the expression of leucocyte function-associated surface antigens' [DOI] [Details]
(1994)'Prevention of restenosis after angioplasty'
Cahill MR, Macey MG, Dawson JR, Newland AC (1994) 'Prevention of restenosis after angioplasty' [Details]
(1994)'Platelets circulate in an activated state in inflammatory bowel disease'
Collins CE, Cahill MR, Newland AC, Rampton DS (1994) 'Platelets circulate in an activated state in inflammatory bowel disease' [Details]
(1993)'Platelet activation in coronary artery disease'
Cahill MR, Newland AC (1993) 'Platelet activation in coronary artery disease' [Details]
(1993)'Clubbing in Crohn's disease'
Collins CE, Cahill MR, Rampton DS (1993) 'Clubbing in Crohn's disease' [Details]
(1993)'Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins, P selectin (CD62) and GP53 (CD63)'
Cahill MR, Macey MG, Newland AC (1993) 'Fixation with formaldehyde induces expression of activation dependent platelet membrane glycoproteins, P selectin (CD62) and GP53 (CD63)' [Details]
(1993)'Protein-A-column plasma immunoadsorption in refractory autoimmune neutropenia and thrombocytopenia'
Bernard T, Kelsey SM, Macey MG, Cahill MR, Howe T, Newland AC (1993) 'Protein-A-column plasma immunoadsorption in refractory autoimmune neutropenia and thrombocytopenia' [Details]
(1993)'von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells'
Collins PW, Macey MG, Cahill MR, Newland AC (1993) 'von Willebrand factor release and P-selectin expression is stimulated by thrombin and trypsin but not IL-1 in cultured human endothelial cells' [Details]
(1991)'Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism?'
Roffe C, Cahill MR, Samanta A, Bricknell S, Durrant ST (1991) 'Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism?' [Details]
(1986)'The measles immunisation programme--early results from Cork'
Cahill, M.,McKiernan, J. (1986) 'The measles immunisation programme--early results from Cork' [Details]

Conference Publications

 YearPublication
(2013)British Society for HaematologyPoster presentation at BSH Liverpool April 2013 (Publication in British Journal Haematology suppl)
JM O’ Sullivan, S Prendeville, TJ Browne, K Feeley, C Duggan, MR Cahill (2013) Review of bone marrow examination quality in a university teaching hospital and referring peripheral hospitals British Society for HaematologyPoster presentation at BSH Liverpool April 2013 (Publication in British Journal Haematology suppl) [Details]

Abstract

 YearPublication
(2012)Minimal Residual Disease Stratification in Fludarabine Ccyclophosphamide Rituximab (FCR) Therapy in Chronic Lymphocytic Leukaemia (CLL.
Hayat, A,O'Brien, D,Quinn, F,Keane, F,Parker, I,Kelly, J,Wieczorkowska, M,Crotty, G,Leahy, M,Enright, H,Hennessy, B,Cahill, M,Vandenberghe, EA (2012) Minimal Residual Disease Stratification in Fludarabine Ccyclophosphamide Rituximab (FCR) Therapy in Chronic Lymphocytic Leukaemia (CLL. Abstract [Details]
(2012)Autophagy As a Target for Differentiation Therapy in Acute Myeloid Leukemia.
Orfali, NM,O'Donovan, T,Nyhan, M,Mongan, NP,Gudas, LJ,Cahill, MR,McKenna, S (2012) Autophagy As a Target for Differentiation Therapy in Acute Myeloid Leukemia. Abstract [Details]
(2012)Induction of Autophagy by Imatinib Sequesters BCR-ABL in Autophagosomes and Reduces BCR-ABL Expression.
Nyhan, M,Elzinga, B,Crowley, L,O'Donovan, T,Orfali, N,O'Sullivan, GC,Cahill, M,McKenna, SL (2012) Induction of Autophagy by Imatinib Sequesters BCR-ABL in Autophagosomes and Reduces BCR-ABL Expression. Abstract [Details]
(2011)Multicentre Retrospective Analysis of Rituximab Use in the Treatment of Steroid Resistant Autoimmune Haemolytic Anaemia in Ireland.
Maung, SW,O'Keeffe, D,Leahy, M,O'Leary, HM,Khan, I,Cahill, M,Galligan, O,Murphy, P,Krawczyk, J,McPherson, S,Jackson, JF,Ryan, M,Hennessy, B,Burke, AC,Enright, H,McHugh, J (2011) Multicentre Retrospective Analysis of Rituximab Use in the Treatment of Steroid Resistant Autoimmune Haemolytic Anaemia in Ireland. Abstract [Details]
(2010)DURATION OF ANTI-HAEMOSTATIC EFFECTS FOLLOWING CESSATION OF CLOPIDOGREL THERAPY AND DUAL CLOPIDOGREL AND ASPIRIN THERAPY.
Cronin, PA,Quinn, EM,Killeen, SD,O'Brien, GC,Andrews, EJ,Cahill, MR,Redmond, HP,Fulton, GJ (2010) DURATION OF ANTI-HAEMOSTATIC EFFECTS FOLLOWING CESSATION OF CLOPIDOGREL THERAPY AND DUAL CLOPIDOGREL AND ASPIRIN THERAPY. Abstract [Details]
(2010)Molecular responses to tyrosine kinase inhibitors in rare, variant e1a2, e6a2 and e19a2 BCR-ABL chronic myeloid leukaemia.
Langabeer, SE,Crampe, M,McCarron, SL,Haslam, K,Connaghan, G,Perera, K,Cahill, MR,Conneally, E (2010) Molecular responses to tyrosine kinase inhibitors in rare, variant e1a2, e6a2 and e19a2 BCR-ABL chronic myeloid leukaemia. Abstract [Details]
(2008)A PHASE 1 CLINICAL TRIAL OF PRION-FILTERED RED CELL CONCENTRATES IN PATIENTS REQUIRING ALLOGENEIC BLOOD TRANSFUSION.
Cahill, MR,Murphy, TM,Fagan, J,Croxon, H,McGrath, S,Gilligan, O,Murphy, W (2008) A PHASE 1 CLINICAL TRIAL OF PRION-FILTERED RED CELL CONCENTRATES IN PATIENTS REQUIRING ALLOGENEIC BLOOD TRANSFUSION. Abstract [Details]
(1999)The effects of ropivacaine hydrochloride on platelet function.
Porter, JM,Crowe, B,Cahill, M,Shorten, GD (1999) The effects of ropivacaine hydrochloride on platelet function. Abstract [Details]
Contribution to teaching in Medicine and Pathology in Cork University Hospital